DiabetesPro SmartBrief

Reading this on a mobile device? Try our optimized mobile version here: https://r.smartbrief.com/resp/dYypCfbwoceSjXvlGKiB

November 6, 2012

News for diabetes health professionals

Diabetes in Focus

Study: Aliskiren does not show heart, kidney benefits in diabetes
Aliskiren-treated type 2 diabetes patients with comorbid kidney or heart disease did not show lower rates of heart attack, stroke or death from cardiovascular and renal disease-related causes at 2.5 years compared with the placebo group, a study indicated. Aliskiren treatment was linked to lower systolic and diastolic blood pressures and higher average decreases in urinary albumin-to-creatinine ratio, but increased incidence of hyperkalemia and hypotension, compared with placebo therapy. The results were presented at Kidney Week 2012 and published in the New England Journal of Medicine. InternalMedicineNews.com (11/5)

Intensive glucose control offers no benefit after kidney transplant
Researchers found statistically similar rates of delayed graft function following kidney transplant in diabetes patients receiving intensive glucose control and a control group. The study in the Journal of Clinical Endocrinology & Metabolism also found an A1C target of less than 180 mg/dL was associated with a lower risk of organ rejection than targets of 70-110 mg/dL, suggesting tight glycemic control may offer no help immediately after the procedure. Modern Medicine/Reuters (11/2)

Review links linagliptin to lower kidney risk in diabetes
An analysis presented at Kidney Week 2012 showed type 2 diabetes patients who took linagliptin were 16% less likely to develop micro- and macroalbuminuria, chronic kidney disease and acute renal failure and showed lower risk of all-cause mortality compared with those in the placebo group. Medscape (free registration) (11/2)

Curbing diabetes complications would have a major economic impact
Data from one of three studies commissioned by the Juvenile Diabetes Research Foundation revealed reducing end-stage renal disease by 50% may help Medicare save up to $475 million for type 1 diabetes and $14 billion for type 2 diabetes after 10 years. In another study, researchers found new glucose-lowering methods may lead to Medicare savings of up to $810 million for type 1 and $45 billion for type 2 diabetes in 10 years. Reducing the severity of type 1 and type 2 diabetes by just 10% and 5%, respectively, could also help save billions in medical costs, researchers said in the third study. HealthNewsDigest.com (11/5)

Nutrition & Wellness

Weight loss curbs inflammation markers in obese
A study presented at the American Heart Association meeting found that low-carb and low-fat diets helped reduce inflammation markers in obese and overweight participants. However, researchers noted that those who were on a low-carb diet lost 28 pounds on average, compared with 18 pounds in those who followed a low-fat diet. DoctorsLounge.com/HealthDay News (11/5)

Fast-food, restaurant dining linked to higher calorie intake
Children and teens had higher calorie intake -- including more sugar and fat -- on days they ate at a fast-food chain or full-service restaurant, according to a study in the Archives of Pediatrics & Adolescent Medicine. Researchers also noted that eating at either restaurant type was associated with a decline in milk intake among children. Reuters (11/5)

Study: Many dieters don't make it past 30 days
About 28% of young people start a new diet regime each month, but 48.9% of all dieters quit after a month, according to a study by weight-loss company Slimsticks. Researchers also found that 48% of dieters change diet plans every six months. MSN/Asian News International (11/5)

Practice Update

CMS finalizes Medicaid rates for primary care docs
All primary care doctors in the fields of family medicine, general internal medicine and pediatric medicine who are serving Medicaid patients will be paid at a rate equivalent to what Medicare offers over the next two years, effective Jan. 1, CMS said. The final rule did not include payment increases for Ob-Gyns and emergency medicine doctors. BeckersHospitalReview.com (11/2)

Trends & Technology

Poll examines physicians' views on health care
A Merritt Hawkins survey revealed 45.8% of female physicians and 40.5% of male physicians were optimistic about the future of their profession, while more than 30% of both groups characterized their morale as positive. Researchers also found 24.7% of female doctors and 16.2% of male doctors believe EMRs will improve care. BeckersHospitalReview.com (11/5)

ADA News

ADA 2013 Harold Rifkin Award: Call for Nominations
Now through Nov. 16, 2012 (8 p.m. EDT), the American Diabetes Association is seeking nominations for the 2013 Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes. This award honors individual outstanding service in the cause of diabetes that has been performed with an international perspective and with international impact. The recipient will receive complimentary housing and registration to attend the 73rd Scientific Sessions, June 21 to 25, at McCormick Place Convention Center in Chicago. Learn more and nominate.

Learn more about DiabetesPro ->

DiabetesPro Home | Professional Education | Journals
Research Grants | Recognition Programs | Membership

SmartQuote

It's impossible to move, to live, to operate at any level without leaving traces, bits, seemingly meaningless fragments of personal information."

--William Gibson,
American-Canadian author

Subscriber Tools

Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise

Account Director: Aaron Kern (202) 407-7866